Beijing Shihong Pharmaceutical Research and Development Center

Beijing Shihong Pharmaceutical Research and Development Center is a specialized pharmaceutical research and development entity located in Beijing, China. It functions as a core R&D subsidiary of Beijing Tide Pharmaceutical, which is a prominent member of the Sino Biopharmaceutical group. The center focuses on the development of high-end generic and innovative drugs, particularly utilizing advanced drug delivery systems such as lipid microspheres and targeted formulations. Its research portfolio is heavily concentrated in hepatology, cardiovascular diseases, and pain management, with a notable emphasis on S-adenosyl-L-methionine (Ademetionine) therapies. Additionally, the center is involved in the development of novel small molecule inhibitors, such as ROCK2 inhibitors for fibrotic diseases. Through its integration with the broader Sino Biopharmaceutical network, the center plays a critical role in translating complex chemical entities into commercially viable specialty medicines.